Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Servier - Precision Medicine: From Early Detection to Improved Outcomes in Patients with IDH Mutations

Conclusion

Date

13 Sep 2024

Session

Servier - Precision Medicine: From Early Detection to Improved Outcomes in Patients with IDH Mutations

Topics

Molecular Oncology;  Genetic and Genomic Testing;  Cancer Research

Tumour Site

Bone Sarcomas;  Acute Myeloid Leukaemia

Presenters

Teresa Macarulla Mercade

Authors

T. Macarulla Mercade

Author affiliations

  • Medical Oncology Dept., Vall d'Hebron Institute of Oncology - Cellex Center, 8035 - Barcelona/ES

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Role of IDH mutations in cancers

Presenter: John Bridgewater

Session: Servier - Precision Medicine: From Early Detection to Improved Outcomes in Patients with IDH Mutations

Resources:

Webcast

Panel Discussion

Presenter: John Bridgewater, Teresa Macarulla Mercade, Ghazaleh Tabatabai, Silvia Stacchiotti

Session: Servier - Precision Medicine: From Early Detection to Improved Outcomes in Patients with IDH Mutations

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.